Oncology Products
Astro Pharma has been active in the field of oncology products for a long time. Our oncology products have a wide range of applications spanning oncology, hematology and dermatology.
With the two biosimilars Herzuma® and Truxima®, Astro Pharma benefits from its many years of experience with high-quality follow-on products from biologics and thus contributes to an expansion of therapeutic options as well as security of supply.
Areas of application are mainly non-Hodgkin’s lymphoma, chronic lymphocytic leukemia and HER2 positive breast cancer.
Astro Pharma has been marketing the hedgehog inhibitor Odomzo® since November 2020. This is used in adults with locally advanced basal cell carcinoma for whom curative surgery or radiotherapy are not an option.
| Product name | Substance |
|---|---|
| Herzuma® 150 mg powder for concentrate for solution for infusion | Trastuzumab |
| Herzuma® 420 mg powder for concentrate for solution for infusion | Trastuzumab |
| Melphalan SUN 50 mg powder for solution for injection or Solution for infusion | Melphalan hydrochloride |
| Odomzo 200 mg hard capsules |
Sonidegib |
| Truxima® 100 mg concentrate for solution for infusion |
Rituximab |
| Truxima® 500 mg concentrate for solution for infusion |
Rituximab |
The Package leaflet can be found on the website of the European Medicines Agency (EMA). If you have any questions about the oncologicals from Astro Pharma, please contact Dr. Sandra Frauer.
Here you will find the conditions for the exchange and return of medicines: Return conditions (only in German)
